12:00 AM
Jan 21, 2013
 |  BC Week In Review  |  Company News  |  Other News

Oculus infectious news

Oculus said its board unanimously approved the spin-off of its biotech business into newco Ruthigen Inc. Oculus said it expects Ruthigen to become a publicly traded company listed...

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >